Related Experiment Video
Updated: Jul 12, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid
Thomas J Nelson1, Daniel L Alkon
1Blanchette Rockefeller Neurosciences Institute, Rockville, Maryland 20850, USA. tjnelson@brni-jhu.org
Abstract:
beta-Amyloid peptide produces apoptosis in neurons at micromolar concentrations, but the mechanism by which beta-amyloid exerts its toxic effect is unknown. The normal biological function of beta-amyloid is also unknown. We used phage display, co-precipitation, and mass spectrometry to examine the protein-protein interactions of beta-amyloid in normal rabbit brain in order to identify the biochemical receptors for beta-amyloid. beta-Amyloid was found to bind primarily to proteins involved in low density lipoprotein and cholesterol transport and metabolism, including sortilin, endoplasmic reticulum-Golgi intermediate compartment 2 (ERGIC2), ERGIC-53, steroid 5alpha-reductase, and apolipoprotein B. beta-Amyloid also bound to the C-reactive protein precursor, a protein involved in inflammation, and to 14-3-3, a protein that regulates glycogen synthase kinase-3beta, the kinase involved in tau phosphorylation. Of eight synthetic peptides identified as targets of beta-amyloid, three were found to be effective blockers of the toxic effect of beta-amyloid on cultured neuronal cells. These peptides bound to the hydrophobic region (residues 17-21) or to the nearby protein kinase C pseudo-phosphorylation site (residues 26-30) of beta-amyloid, suggesting that these may be the most critical regions for beta-amyloid effector action and for aggregation. Peptides or other small molecules that bind to this region may protect against beta-amyloid toxic effect by competitively blocking its ability to bind beta-amyloid effector proteins such as sortilin and 14-3-3.
Insights
Beta-amyloid peptide toxicity in neurons is linked to its interaction with cholesterol transport proteins. Blocking specific beta-amyloid regions with peptides may prevent neuronal damage.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- The mechanism of beta-amyloid peptide-induced neuronal apoptosis remains unclear.
- The physiological role of beta-amyloid peptide is currently unknown.
- Understanding beta-amyloid's interactions is crucial for Alzheimer's disease research.
Purpose of the Study:
- To identify the protein-protein interactions and biochemical receptors for beta-amyloid peptide in the brain.
- To elucidate the normal biological function of beta-amyloid peptide.
- To discover potential therapeutic targets for blocking beta-amyloid toxicity.
Main Methods:
- Utilized phage display, co-precipitation, and mass spectrometry to analyze beta-amyloid interactions.
- Examined protein-protein binding in normal rabbit brain tissue.
- Synthesized and tested peptides for their ability to block beta-amyloid's toxic effects.
Main Results:
- Beta-amyloid peptide primarily binds to proteins involved in cholesterol and lipoprotein transport, including sortilin, ERGIC2, ERGIC-53, steroid 5alpha-reductase, and apolipoprotein B.
- Beta-amyloid also interacts with C-reactive protein (inflammation) and 14-3-3 (regulating tau phosphorylation kinase).
- Three synthetic peptides targeting beta-amyloid's hydrophobic region (residues 17-21) or pseudo-phosphorylation site (residues 26-30) effectively blocked neuronal toxicity.
Conclusions:
- Beta-amyloid peptide's toxic effects may stem from its interactions with cholesterol transport and inflammatory pathways.
- Specific regions of beta-amyloid are critical for its biological activity and aggregation.
- Therapeutic strategies targeting these critical regions could offer neuroprotection against beta-amyloid toxicity.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Extrinsic Apoptotic Pathway
Apoptosis

